etoposide has been researched along with Neurofibromatosis 1 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Kakuda, Y; Katagiri, H; Miyagi, M; Murata, H; Takahashi, M; Wang, Y; Wasa, J | 1 |
Igawa, Y; Kinebuchi, Y; Nishizawa, O; Noguchi, W | 1 |
Cohen, IJ; Horev, G; Kornreich, L; Michowiz, S; Shuper, A; Weitz, R; Zaizov, R | 1 |
Hotta, T; Imaizumi, S; Motoyama, T; Ogose, A; Takahashi, HE | 1 |
Haque, AK; Mathew, P; Roberts, JA; Zwischenberger, J | 1 |
Carbone, TV; Kelleher, JF | 1 |
1 review(s) available for etoposide and Neurofibromatosis 1
Article | Year |
---|---|
Monosomy 7 syndrome in an infant with neurofibromatosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosomes, Human, Pair 7; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Diagnosis, Differential; Etoposide; Humans; Infant; Leukemia, Myelomonocytic, Chronic; Male; Monocytes; Monosomy; Neurofibromatosis 1; Pedigree; Preleukemia; Syndrome; Thioguanine | 1991 |
5 other study(ies) available for etoposide and Neurofibromatosis 1
Article | Year |
---|---|
Metastatic Malignant Peripheral Nerve Sheath Tumor With NF1 Successfully Treated With 'Gradual Subtraction' ICE Chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Metastasis; Nerve Sheath Neoplasms; Neurofibromatosis 1; Prognosis | 2020 |
Recurrent retroperitoneal malignant nerve sheath tumor associated with neurofibromatosis type 1 responding to carboplatin and etoposide combined chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Lung Neoplasms; Male; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Retroperitoneal Neoplasms | 2005 |
Visual pathway glioma: an erratic tumour with therapeutic dilemmas.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Cranial Nerve Neoplasms; Cyclophosphamide; Dactinomycin; Etoposide; Female; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Neurofibromatosis 1; Optic Chiasm; Optic Nerve Diseases; Vincristine; Visual Cortex | 1997 |
Characterization and chemosensitivity of two human malignant peripheral nerve sheath tumour cell lines derived from a patient with neurofibromatosis type 1.
Topics: Adult; Animals; DNA Primers; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Immunoenzyme Techniques; Karyotyping; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Polymerase Chain Reaction; Retroperitoneal Neoplasms; S100 Proteins; Translocation, Genetic; Tretinoin; Tumor Cells, Cultured | 1998 |
Mediastinal atypical carcinoid and neurofibromatosis type 1.
Topics: Carcinoid Tumor; Cell Nucleus; Cisplatin; Etoposide; Female; Humans; Mediastinal Neoplasms; Middle Aged; Mitochondria; Neurofibromatosis 1; Palliative Care; Radiography, Thoracic; Tomography, X-Ray Computed | 2000 |